لا تُقدم XM خدماتها لمواطني الولايات المتحدة الأمريكية.
B
B

BayerAG


أخبار

Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio

BRIEF-Bayer to Present New Prostate Cancer Data and Continued Oncology Portfolio Sept 4 (Reuters) - BAYER AG BAYGn.DE WILL PRESENT PRIMARY RESULTS FROM THE PHASE III ARANOTE TRIAL IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC) FOR NUBEQA(®)(DAROLUTAMIDE) AS A LATE-BREAKING ORAL PRESENTATION WILL PRESENT PRIMARY RESULTS FROM THE EUROPEAN O
B

VW row flags Germany’s creaking corporate model

BREAKINGVIEWS-VW row flags Germany’s creaking corporate model The author is a Reuters Breakingviews columnist. The opinions expressed are his own. By Pierre Briancon BERLIN, Sept 5 (Reuters Breakingviews) - A company whose chief financial officer says it only has “one, maybe two” years to turn around its core brand must have done something wrong.
B
B
T
V

Bayer To Unveil New Data From Its Phase III Oasis 3 Long-Term Study Of Elinzanetant

BRIEF-Bayer To Unveil New Data From Its Phase III Oasis 3 Long-Term Study Of Elinzanetant Sept 4 (Reuters) - BAYER AG BAYGn.DE : TO UNVEIL NEW DATA FROM ITS PHASE III OASIS 3 LONG-TERM STUDY OF ELINZANETANT IN TREATMENT OF VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE BAYER WILL PRESENT DETAILED RESULTS SEPTEMBER 10 - 14 Further company coverage: [B
B

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Telia Sept 4 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest freight co
B
B
B
C
I
N
T
T
U
V
B
U

US will still pay at least twice as much after negotiating drug prices

UPDATE 1-US will still pay at least twice as much after negotiating drug prices U.S. pays higher drug prices, gets priority access Medicare's negotiated prices most significant for drugs with little competition Goal is to balance affordability and innovation Updates first graphic to align colors representing countries with second graphic By Deena Beasley Sept 3 (Reuters) - The U.S.
A
A
B
N
P

Bayer: Bluerock Gets FDA Clearance Of Application For Photoreceptor Diseases Treatment

BRIEF-Bayer: Bluerock Gets FDA Clearance Of Application For Photoreceptor Diseases Treatment Sept 3 (Reuters) - Bayer AG BAYGn.DE : BLUEROCK THERAPEUTICS ANNOUNCES FDA CLEARANCE OF IND APPLICATION FOR INVESTIGATIONAL IPSC-DERIVED CELL THERAPY OPCT-001 FOR TREATMENT OF PRIMARY PHOTORECEPTOR DISEASES Further company coverage: [BAYGn.DE] (Gdansk Newsr
B

US will still pay at least twice as much after negotiating drug prices

ANALYSIS-US will still pay at least twice as much after negotiating drug prices U.S. pays higher drug prices, gets priority access Medicare's negotiated prices most significant for drugs with little competition Goal is to balance affordability and innovation By Deena Beasley Sept 3 (Reuters) - The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases five times, what drugmakers have agreed to in four other high-income count
A
A
B
N
P

Bayer rises after positive kidney drug study in heart failure

CORRECTED-BUZZ-Bayer rises after positive kidney drug study in heart failure Corrects trial name in 2nd bullet; updates share performance in 1st and 5th bullet ** Shares in Bayer BAYGn.DE rise 0.6% after the German firm said its kidney drug Kerendia helped patients avoid complications from a common form of heart failure ** The late-stage FINEARTS-H
B
G

Bayer Shares Finerenone Update

BRIEF-Bayer Shares Finerenone Update Sept 2 (Reuters) - BAYER AG BAYGn.DE : SAID ON SUNDAY FINERENONE SHOWED SIGNIFICANT IMPROVEMENT IN CARDIOVASCULAR OUTCOMES IN ADULTS WITH COMMON FORM OF HEART FAILURE WITH HIGH UNMET MEDICAL NEED Source text for Eikon: ID:nNDL72qgt8 Further company coverage: [BAYGn.DE] (Gdansk Newsroom)
B

Germany corporate earnings week ahead

DIARY-Germany corporate earnings week ahead Aug 30 (Reuters) - Diary of Germany (.GDAXI) corporate earnings for the week ahead GERMANY EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP ** All times are listed in AMC - 'After market close', or BMO - 'Before market opens', or DBH - 'During business hours', or NTS - 'No time scheduled' ** This Diary does not provide the EPS estimate fig
B
G

Europe's STOXX 600 corporate earnings week ahead

DIARY-Europe's STOXX 600 corporate earnings week ahead Aug 30 (Reuters) - Diary of Europe's STOXX 600 (.STOXX) corporate earnings for the week ahead EUROPE'S STOXX 600 EARNINGS Start Date Start Time (GMT) RIC Company Name Event Name 02-Sep-2024 09:00 BAYGn.DE Bayer AG Bayer AG Investor Webinar to Discuss Results from FINEARTS-HFP 02-Sep-2024 09:00 PZU.WA Powszechny Zaklad Ubezpieczen SA Half Year 2024 Powszechny Zaklad Ubezpieczen SA Investor Chat (Polish) 03-Sep-2024 NTS BKWB.S BKW AG Half Year
A
B
B
B
H
R
S
D
S

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Shell Aug 30 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest freight co
B
B
B
C
I
N
T
T
U
V
B
U

Bayer Starts Late Stage Trial In Lung Cancer Therapy

BRIEF-Bayer Starts Late Stage Trial In Lung Cancer Therapy Aug 29 (Reuters) - Bayer AG BAYGn.DE : STARTS PHASE III TRIAL IN NON-SMALL CELL LUNG CANCER (NSCLC) FIRST PATIENT ENROLLED IN PHASE III SOHO-02 TRIAL OF INVESTIGATIONAL AGENT BAY 2927088 IN TREATMENT-NAÏVE PATIENTS WITH ADVANCED NSCLC WITH HER2-ACTIVATING MUTATIONS DATA FROM PHASE I/II SOH
B

ADNOC finalising due diligence on Covestro, sources say

UPDATE 1-ADNOC finalising due diligence on Covestro, sources say Adds details, background in paragraphs 4-8 By Emma-Victoria Farr FRANKFURT, Aug 28 (Reuters) - Abu Dhabi National Oil Company (ADNOC) is finalising due diligence for a takeover of Covestro 1COV.DE in a deal that could reach 11.7 billion euros ($13 billion), two sources familiar with the matter told Reuters on Wednesday.
B

Bayer Says Co And NextRNA Therapeutics Enter Strategic Collaboration To Develop Small Molecules Targeting Long Non-Coding RNAs In Oncology

BRIEF-Bayer Says Co And NextRNA Therapeutics Enter Strategic Collaboration To Develop Small Molecules Targeting Long Non-Coding RNAs In Oncology Aug 28 (Reuters) - Bayer AG BAYGn.DE : BAYER AND NEXTRNA THERAPEUTICS ENTER STRATEGIC COLLABORATION TO DEVELOP SMALL MOLECULES TARGETING LONG NON-CODING RNAS (LNCRNAS) IN ONCOLOGY BAYER AG: NEXTRNA WILL RE
B

Bayer To Collaborate With NextRNA In Oncology Treatment

BRIEF-Bayer To Collaborate With NextRNA In Oncology Treatment Aug 28 (Reuters) - Bayer AG BAYGn.DE : ENTERS COLLABORATION WITH NEXTRNA TO DEVELOP SMALL MOLECULES TARGETING LONG NON-CODING RNAS IN ONCOLOGY NEXTRNA WILL RECEIVE UP TO $547 MILLION FOR TWO ONCOLOGY PROGRAMS Further company coverage: [BAYGn.DE] (Gdansk Newsroom)
B

US says Bioceres genetically modified wheat safe to grow

UPDATE 3-US says Bioceres genetically modified wheat safe to grow Updates Aug 27 story, adds comments from Bioceres in paragraphs 2-3 and 11; from Japan in paragraphs 13-14; and a German grain trader in paragraph 16 By Tom Polansek and Julie Ingwersen CHICAGO, Aug 28 (Reuters) - A type of genetically modified wheat developed by Argentina's Bioceres Crop Solutions BIOX.O may be safely grown in the United States, the U.S.
B

European companies cut jobs as economy sputters

FACTBOX-European companies cut jobs as economy sputters Adds Tamedia, UPM Aug 27 (Reuters) - Elevated levels of inflation and the impact of the war in Ukraine have forced companies across Europe to freeze hiring or cut jobs. Here are some of the layoffs announced since the start of April: BANKS * TSB: The British bank owned by Spain's Sabadell SABE.MC is seeking 250 job cuts, its spokesperson and employee union said on May 8. INDUSTRIALS AND ENGINEERING * PKP CARGO PKPP.WA : Poland's largest fre
B
B
B
C
I
N
T
T
U
V
B
U

Bayer: Will Present Phase III Data On Finerenone

BRIEF-Bayer: Will Present Phase III Data On Finerenone Aug 26 (Reuters) - Bayer AG BAYGn.DE : ADVANCING IN STUDIES ON HEART FAILURE MANAGEMENT SHOWCASING LATE-BREAKING HEART FAILURE DATA FROM PHASE III STUDY FINEARTS-HF WITH FINERENONE WILL PRESENT LATE-BREAKING PHASE III DATA ON FINERENONE (KERENDIA™) IN PATIENTS WITH HEART FAILURE (HF) AND A LE
B

Bayer Reports JAMAs Phase III Data On Elinzanetant

BRIEF-Bayer Reports JAMAs Phase III Data On Elinzanetant Aug 22 (Reuters) - BAYER AG BAYGn.DE : JOURNAL OF AMERICAN MEDICAL ASSOCIATION (JAMA) PUBLISHES ELINZANETANT PHASE III DATA OASIS 1 AND 2 STUDIES DEMONSTRATED POSITIVE RESULTS FOR INVESTIGATIONAL COMPOUND ELINZANETANT WHICH MET ALL PRIMARY ENDPOINTS Further company coverage: [BAYGn.DE] (Gdans
B



الشروط

الأصول الشائعة

إخلاء المسؤولية: تتيح كيانات XM Group خدمة تنفيذية فقط والدخول إلى منصة تداولنا عبر الإنترنت، مما يسمح للشخص بمشاهدة و/أو استخدام المحتوى المتاح على موقع الويب أو عن طريقه، وهذا المحتوى لا يراد به التغيير أو التوسع عن ذلك. يخضع هذا الدخول والاستخدام دائماً لما يلي: (1) الشروط والأحكام؛ (2) تحذيرات المخاطر؛ (3) إخلاء المسؤولية الكامل. لذلك يُقدم هذا المحتوى على أنه ليس أكثر من معلومات عامة. تحديداً، يرجى الانتباه إلى أن المحتوى المتاح على منصة تداولنا عبر الإنترنت ليس طلباً أو عرضاً لدخول أي معاملات في الأسواق المالية. التداول في أي سوق مالي به مخاطرة عالية برأس مالك.

جميع المواد المنشورة على منصة تداولنا مخصصة للأغراض التعليمية/المعلوماتية فقط ولا تحتوي - ولا ينبغي اعتبار أنها تحتوي - على نصائح أو توصيات مالية أو ضريبية أو تجارية، أو سجلاً لأسعار تداولنا، أو عرضاً أو طلباً لأي معاملة في أي صكوك مالية أو عروض ترويجية مالية لا داعي لها.

أي محتوى تابع للغير بالإضافة إلى المحتوى الذي أعدته XM، مثل الآراء، والأخبار، والأبحاث، والتحليلات والأسعار وغيرها من المعلومات أو روابط مواقع تابعة للغير وواردة في هذا الموقع تُقدم لك "كما هي"، كتعليق عام على السوق ولا تعتبر نصيحة استثمارية. يجب ألا يُفسر أي محتوى على أنه بحث استثماري، وأن تلاحظ وتقبل أن المحتوى غير مُعدٍ وفقاً للمتطلبات القانونية المصممة لتعزيز استقلالية البحث الاستثماري، وبالتالي، فهو بمثابة تواصل تسويقي بموجب القوانين واللوائح ذات الصلة. فضلاً تأكد من أنك قد قرأت وفهمت الإخطار بالبحوث الاستثمارية غير المستقلة والتحذير من مخاطر المعلومات السابقة، والذي يمكنك الاطلاع عليه هنا.

تحذير المخاطر: رأس مالك في خطر. المنتجات التي تستخدم الرافعة قد لا تكون مناسبة للجميع. يرجى الاطلاع على تنبيه المخاطر.